Product
PD-1 Antibody
1 clinical trial
3 indications
Indication
Lynch SyndromeIndication
MSI-H Colorectal CancerIndication
Colorectal CancerClinical trial
PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal CancerStatus: Active (not recruiting), Estimated PCD: 2024-04-22